Other Income/Expenses (Net)

$402.90M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$402.90Mperiod endingJun 30, 2026

VRTX Other Income/Expenses (Net) ($4.10M → $402.90M)

Annual Other Income/Expenses (Net)

High-resolution chart · PNG

VRTX other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period ending	Other Income/Expenses (Net) (USD)
Dec 31, 2025	-117,500,000
Dec 31, 2024	481,400,000
Dec 31, 2023	547,800,000
Dec 31, 2022	-75,000,000
Dec 31, 2021	-51,700,000
Dec 31, 2020	260,600,000
Dec 31, 2019	197,419,000
Dec 31, 2018	-34,909,000
Dec 31, 2017	-138,932,000
Dec 31, 2016	-77,302,000
Dec 31, 2015	-90,921,000
Dec 31, 2014	-42,463,000
Dec 31, 2013	-366,109,000
Dec 31, 2012	-59,108,000
Dec 31, 2011	-53,375,000
Dec 31, 2010	-58,549,000
Dec 31, 2009	-28,166,000
Dec 31, 2008	2,857,000
Dec 31, 2007	28,513,000
Dec 31, 2006	21,101,000
Dec 31, 2005	-53,545,000
Dec 31, 2004	-11,440,000
Dec 31, 2003	67,760,000
Dec 31, 2002	28,299,000
Dec 31, 2001	-2,789,000
Dec 31, 2000	-16,164,000
Dec 31, 1999	10,300,000
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	5,500,000
Dec 31, 1994	3,600,000
Dec 31, 1993	900,000
Dec 31, 1992	2,000,000
Dec 31, 1991	800,000
Dec 31, 1990	4,100,000